Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

Who May Qualify: - • Male \& female osteoporotic patient aged ≥ 50 years - Hypertensive \& normotensive patients - BMD T-score ≥ 2.5 or more SD below peak bone mass Who Should NOT Join This Trial: - Patients on drugs that may improve osteoporosis disease state such as: - Angiotensin converting enzyme inhibitor (ACEI) or Angiotensin receptor blockers (ARBs), Thiazide diuretic, Nitrates, Spironolactone, Statins. Patients on drugs that may worsen osteoporosis disease state such as: • Corticosteroids, Loop diuretics, Anticonvulsants, Antidepressants, Aromatase inhibitors, Thyroid replacement therapy and Proton pump inhibitors. Always talk to your doctor about whether this trial is right for you.